{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:32:09Z","timestamp":1787761929966,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with a spectrum of presentation. Studies have reported considerably different rates in terms of the incidence of polycystic ovary morphology (PCOM) in patients with PCOS with inconsistent results regarding the effects of PCOM in them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of this study was to determine the differences in clinical presentation, metabolic profile, hormonal parameters and inflammatory markers in PCOS women with and without PCOM on ultrasonography (USG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>A total of 70 PCOS women were recruited. To analyse the differences between various parameters, the patients were divided into two groups based on the presence or absence of PCOM on USG of the pelvis as per the Rotterdam criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of 37 patients had PCOM as per the diagnostic criteria for PCOS (Group 1), while 33 patients did not have PCOM on USG and were designated as Group 2. All participants underwent a detailed clinical evaluation and biochemical investigations, including high-sensitivity C-reactive protein, serum adiponectin, luteinising hormone, follicle-stimulating hormone, total testosterone and serum anti-Mullerian hormone. The homeostasis model assessment of IR (HOMA-IR) was calculated using standard equations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      The mean and Standard deviation were computed for all continuous variables. Frequencies and proportions were calculated for categorical variables. Comparisons of the mean scores between the study groups were assessed using the Unpaired Student's\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test. The mean score of the subgroups was also compared using the unpaired Student's\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was considered significant for all statistical inferences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean LDL and mean triglyceride were higher in Group 2, which was statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.001, respectively). The mean hs-CRP was found to be higher in Group 2, which was statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005). The mean AMH was higher in Group 1, which was statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002). Group 1 had higher adiponectin levels, which was statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The above findings suggest that patients without diagnostic PCO morphology have a worse metabolic profile compared to those with PCO morphology on USG. Obese patients without PCO morphology probably have a higher cardiovascular risk compared to obese patients with PCO morphology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_60_23","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T06:51:37Z","timestamp":1689144697000},"page":"132-139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance"],"prefix":"10.4103","volume":"16","author":[{"given":"Sweekruti","family":"Jena","sequence":"first","affiliation":[{"name":"Department of Endocrinology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipsita","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoj Kumar","family":"Baliarsinha","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarchan","family":"Jena","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Debata","sequence":"additional","affiliation":[{"name":"Department of Radiology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"ref2-20240905","first-page":"336","article-title":"Polycystic ovary syndrome: A review of treatment options with a focus on pharmacological approaches","volume":"38","author":"Ndefo","year":"2013","journal-title":"P T"},{"key":"ref3-20240905","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4-20240905","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"ref7-20240905","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0015-0282(97)80068-4","article-title":"Classification of normogonadotropic infertility: Polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome","volume":"67","author":"van Santbrink","year":"1997","journal-title":"Fertil Steril"},{"key":"ref8-20240905","doi-asserted-by":"crossref","first-page":"719050","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: Navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"ref9-20240905","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5539\/gjhs.v7n2p101","article-title":"Body mass index and gonadotropin hormones (LH and FSH) associate with clinical symptoms among women with polycystic ovary syndrome","volume":"7","author":"Esmaeilzadeh","year":"2014","journal-title":"Glob J Health Sci"},{"key":"ref10-20240905","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpag.2014.07.016","article-title":"The polycystic ovary morphology-polycystic ovary syndrome spectrum","volume":"28","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref11-20240905","doi-asserted-by":"crossref","first-page":"742","DOI":"10.12669\/pjms.323.10082","article-title":"Correlation between ovarian morphology and biochemical and hormonal parameters in polycystic ovary syndrome","volume":"32","author":"Inan","year":"2016","journal-title":"Pak J Med Sci"},{"key":"ref12-20240905","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"ref13-20240905","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"ref14-20240905","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref15-20240905","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref16-20240905","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"ref17-20240905","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"ref18-20240905","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF03345285","article-title":"Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome","volume":"27","author":"Faloia","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"ref19-20240905","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4239\/wjd.v13.i1.5","article-title":"Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review","volume":"13","author":"Livadas","year":"2022","journal-title":"World J Diabetes"},{"key":"ref20-20240905","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diacare.24.3.460","article-title":"Diagnosing insulin resistance in the general population","volume":"24","author":"McAuley","year":"2001","journal-title":"Diabetes Care"},{"key":"ref21-20240905","doi-asserted-by":"crossref","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"key":"ref22-20240905","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.3390\/cells11203255","article-title":"Increased prevalence of elevated DHEAS in PCOS women with non-classic (B or C) phenotypes: A retrospective analysis in patients aged 20 to 29 years","volume":"11","author":"Carmina","year":"2022","journal-title":"Cells"},{"key":"ref23-20240905","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"ref24-20240905","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: A case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25-20240905","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"ref26-20240905","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: A marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27-20240905","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","article-title":"The serine phosphorylation hypothesis of polycystic ovary syndrome: A unifying mechanism for hyperandrogenemia and insulin resistance","volume":"89","author":"Bremer","year":"2008","journal-title":"Fertil Steril"},{"key":"ref28-20240905","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29-20240905","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1469-0705.1994.04010054.x","article-title":"Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women","volume":"4","author":"Farquhar","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref30-20240905","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jadohealth.2017.09.005","article-title":"Ovarian morphology by transabdominal ultrasound correlates with reproductive and metabolic disturbance in adolescents with PCOS","volume":"62","author":"Rackow","year":"2018","journal-title":"J Adolesc Health"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_60_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:12:12Z","timestamp":1787760732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_60_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_60_23","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2023-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}